Daily non-political popular news in brief.

Longer anthracycline therapy reduces heart failure in adult cancer patients

Stretching out a dose of chemotherapy over six or more hours may reduce the risk of heart problems caused by certain commonly used cancer drugs, according to a new review of recent research.

Read more »

Keywords: longer, anthracycline, therapy, heart, failure, adult, cancer, patients, patient

« Previous | Next »

Similar news on "Longer anthracycline therapy reduces heart failure in adult cancer patients":

1. Pre-treatment blood test could guide lung cancer therapy
   06-05-2007 · EurekAlert!
   A multi-center team, led by Vanderbilt-Ingram Cancer Center investigators, has developed a new pre-treatment blood test that predicts which non-small-cell lung cancer patients will live longer when they are treated with certain targeted cancer therapies (Iressa, Tarceva). The mass spectrometry-based test, described in the June 6 Journal of the National Cancer Institute, may allow physicians to select the most beneficial therapy for each lung cancer patient, a step forward in the era of personalized medicine.
   Similar news · Read more »
   
2. Rx for heart failure: Patient-centered care from a pharmacist
   05-14-2007 · EurekAlert!
   Heart failure patients have fewer emergency room visits and hospital stays and take their medicine more reliably when under the care of a pharmacist trained in patient-centered care.
   Similar news · Read more »
   
3. Advanced therapy offers cure for relapsed cancer patient
   07-25-2007 · EurekAlert!
   Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine study by Lawrence Einhorn, M.D.; Stephen Williams, M.D.; Rafat Abonour, M.D., and colleagues published in the July 26 issue of the New England Journal of Medicine. Although the number of relapsed testicular cancer patients in the US is small, the IU Simon Cancer Center treats a majority of them.
   Similar news · Read more »
   
4. UCLA researchers discover biomarkers that predict lung cancer patient response to therapy
   01-31-2008 · EurekAlert!
   Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
   Similar news · Read more »
   
5. Remote device allows cardiologist to monitor patients daily at their homes
   01-31-2007 · EurekAlert!
   An easy-to-use in home monitoring device for patients is changing the way doctors monitor the health of patients with implanted defibrillators. Rush University Medical Center is participating in a pilot study of the Latitude Patient Management system to determine if the wireless home monitoring system can decrease hospitalizations for heart failure.
   Similar news · Read more »
   
6. Study puts brakes on extending indications for cardiac resynchronization therapy
   11-06-2007 · EurekAlert!
   A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in patients with Class III heart failure, including mechanical problems that disrupt the heart's normal rhythm and a moderately prolonged QRS complex as demonstrated on EKG.
   Similar news · Read more »
   
7. Researchers discover 'sticky' proteins fuse adult stem cells to cardiac muscle, repairing hearts
   02-15-2007 · EurekAlert!
   Cardiologists are increasingly using adult stem cells in clinical trials to repair hearts following heart attacks, but no one has understood how the therapy actually works. Now, in animal experiments, researchers at the University of Texas M. D. Anderson Cancer Center have deconstructed the process, describing how the stem cells fuse with heart muscle cells to create new cells that repopulate the ailing organ.
   Similar news · Read more »
   
8. Study finds limited options for backup HIV treatment in some developing countries
   01-08-2007 · EurekAlert!
   Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. Since catching treatment failure early is key to preventing further resistance, this research, published in the February 1 issue of Clinical Infectious Diseases also argues for greater access in the developing world to tests that detect when the amount of virus in a patient's blood is increasing.
   Similar news · Read more »
   
9. New study reports improved treatment and reduced mortality for patients with heart failure
   05-01-2007 · EurekAlert!
   UCLA researchers tracked heart failure in-hospital patient trends from 2002 to 2004 for 285 hospitals nationwide and found significant changes in treatment patterns and quality-of-care indicators that paralleled improvements in clinical outcomes and mortality.
   Similar news · Read more »
   
10. Firefly genes allow testing of new therapy against lymphoma
    12-19-2007 · EurekAlert!
    Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
    Similar news · Read more »